{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:50:17Z","timestamp":1779144617658,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2177,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.virol.2007.03.001","type":"journal-article","created":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T07:13:24Z","timestamp":1176275604000},"page":"431-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes"],"prefix":"10.1016","volume":"364","author":[{"given":"Thomas J.","family":"Ketas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Schader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Polonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Johan","family":"Klasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.virol.2007.03.001_bib1","doi-asserted-by":"crossref","first-page":"13232","DOI":"10.1128\/JVI.78.23.13232-13252.2004","article-title":"Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies","volume":"78","author":"Binley","year":"2004","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2007.03.001_bib2","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1128\/JVI.79.10.6089-6101.2005","article-title":"Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines","volume":"79","author":"Brown","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2007.03.001_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/431519","article-title":"Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals","volume":"192","author":"Brumme","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2007.03.001_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2000.0239","article-title":"Antibody and virus: binding and neutralization","volume":"270","author":"Burton","year":"2000","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2007.03.001_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ni0304-233","article-title":"HIV vaccine design and the neutralizing antibody problem","volume":"5","author":"Burton","year":"2004","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.virol.2007.03.001_bib6","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1128\/JVI.77.7.4449-4456.2003","article-title":"The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C","volume":"77","author":"Cilliers","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2007.03.001_bib7","doi-asserted-by":"crossref","DOI":"10.1021\/bi7001289","article-title":"Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor","author":"Deng","year":"2007","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.virol.2007.03.001_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1086\/499163","article-title":"Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection","volume":"193","author":"Dhawan","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2007.03.001_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0005-2736(03)00161-5","article-title":"The HIV Env-mediated fusion reaction","volume":"1614","author":"Gallo","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"19","key":"10.1016\/j.virol.2007.03.001_bib10","doi-asserted-by":"crossref","first-page":"10528","DOI":"10.1128\/JVI.77.19.10528-10536.2003","article-title":"Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120\u2013CD4 interactions","volume":"77","author":"Guo","year":"2003","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2007.03.001_bib11","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1371\/journal.pmed.0030079","article-title":"How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?","volume":"3","author":"Gupta","year":"2006","journal-title":"PLoS Med."},{"issue":"10","key":"10.1016\/j.virol.2007.03.001_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri1706","article-title":"Perils at mucosal front lines for HIV and SIV and their hosts","volume":"5","author":"Haase","year":"2005","journal-title":"Nat. Rev., Immunol."},{"issue":"5","key":"10.1016\/j.virol.2007.03.001_bib13","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bcp.2005.05.035","article-title":"AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor","volume":"70","author":"Hatse","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.virol.2007.03.001_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","article-title":"Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1","volume":"26","author":"Hladik","year":"2007","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.virol.2007.03.001_bib15","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.77.4.2762-2767.2003","article-title":"Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells","volume":"77","author":"Ketas","year":"2003","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2007.03.001_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/088922203763315678","article-title":"Entry inhibitors SCH-C, RANTES, and T-20 block HIV type 1 replication in multiple cell types","volume":"19","author":"Ketas","year":"2003","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"9","key":"10.1016\/j.virol.2007.03.001_bib17","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","article-title":"Occupancy and mechanism in antibody-mediated neutralization of animal viruses","volume":"83","author":"Klasse","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"9","key":"10.1016\/j.virol.2007.03.001_bib18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1371\/journal.pmed.0030351","article-title":"Which topical microbicides for blocking HIV-1 transmission will work in the real world?","volume":"3","author":"Klasse","year":"2006","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.virol.2007.03.001_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1848","article-title":"Microbicides and other topical strategies to prevent vaginal transmission of HIV","volume":"6","author":"Lederman","year":"2006","journal-title":"Nat. Immunol. Rev."},{"issue":"22","key":"10.1016\/j.virol.2007.03.001_bib20","doi-asserted-by":"crossref","first-page":"11964","DOI":"10.1128\/JVI.77.22.11964-11972.2003","article-title":"Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector","volume":"77","author":"Lee","year":"2003","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.virol.2007.03.001_bib21","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2007.03.001_bib22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/aid.2006.22.411","article-title":"Cellulose acetate 1,2-benzenedicarboxylate inhibits infection by cell-free and cell-associated primary HIV-1 isolates","volume":"22","author":"Lu","year":"2006","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"4","key":"10.1016\/j.virol.2007.03.001_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrmicro1387","article-title":"Selective transmission of CCR5-utilizing HIV-1: the \u2018gatekeeper\u2019 problem resolved?","volume":"4","author":"Margolis","year":"2006","journal-title":"Nat. Rev., Microbiol."},{"issue":"16","key":"10.1016\/j.virol.2007.03.001_bib24","doi-asserted-by":"crossref","first-page":"10103","DOI":"10.1128\/JVI.79.16.10103-10107.2005","article-title":"Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines","volume":"79","author":"Mascola","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2007.03.001_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd1331","article-title":"Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes","volume":"3","author":"Matthews","year":"2004","journal-title":"Nat. Rev., Drug Discov."},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2007.03.001_bib26","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/jmv.20599","article-title":"Global epidemiology of HIV","volume":"78","author":"McCutchan","year":"2006","journal-title":"J. Med. Virol."},{"issue":"14","key":"10.1016\/j.virol.2007.03.001_bib27","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.79.14.9217-9227.2005","article-title":"Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus","volume":"79","author":"Miller","year":"2005","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2007.03.001_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nm0804-769","article-title":"Urgently needed: a filter for the HIV-1 vaccine pipeline","volume":"10","author":"Moore","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.virol.2007.03.001_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/088922204322749567","article-title":"The CCR5 and CXCR4 coreceptors \u2013 central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection","volume":"20","author":"Moore","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"6","key":"10.1016\/j.virol.2007.03.001_bib30","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/428096","article-title":"Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection","volume":"191","author":"Moyle","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.virol.2007.03.001_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1568005033481015","article-title":"Resistance to HIV-1 entry inhibitors","volume":"3","author":"Olson","year":"2003","journal-title":"Curr. Drug Targets, Infect. Disord."},{"issue":"10","key":"10.1016\/j.virol.2007.03.001_bib32","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1128\/jvi.71.10.8001-8007.1997","article-title":"Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism","volume":"71","author":"Pope","year":"1997","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.virol.2007.03.001_bib33","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1128\/JVI.79.13.8454-8469.2005","article-title":"Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors","volume":"79","author":"Rusert","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2007.03.001_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrmicro729","article-title":"Inhibiting sexual transmission of HIV-1 infection","volume":"1","author":"Shattock","year":"2003","journal-title":"Nat. Rev., Microbiol."},{"issue":"5","key":"10.1016\/j.virol.2007.03.001_bib35","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/AAC.46.5.1336-1339.2002","article-title":"Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro","volume":"46","author":"Tremblay","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.virol.2007.03.001_bib36","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/135965350501000801","article-title":"TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro","volume":"10","author":"Tremblay","year":"2005","journal-title":"Antiviral Ther."},{"issue":"8","key":"10.1016\/j.virol.2007.03.001_bib37","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1128\/AAC.49.8.3483-3485.2005","article-title":"TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro","volume":"49","author":"Tremblay","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.virol.2007.03.001_bib38","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1128\/JVI.72.3.1876-1885.1998","article-title":"Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage","volume":"72","author":"Trkola","year":"1998","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2007.03.001_bib39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/JVI.75.2.579-588.2001","article-title":"Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140","volume":"75","author":"Trkola","year":"2001","journal-title":"J. Virol."},{"issue":"7064","key":"10.1016\/j.virol.2007.03.001_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature04055","article-title":"Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus\u2013cell fusion","volume":"438","author":"Veazey","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.virol.2007.03.001_bib41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/88656","article-title":"Immune control of HIV: the obstacles of HLA and viral diversity","volume":"2","author":"Walker","year":"2001","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.virol.2007.03.001_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.antiviral.2005.07.006","article-title":"Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density","volume":"68","author":"Willey","year":"2005","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.virol.2007.03.001_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jama.292.2.251","article-title":"Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society\u2014USA Panel","volume":"292","author":"Yeni","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.virol.2007.03.001_bib44","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/JVI.79.3.1480-1486.2005","article-title":"Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes","volume":"79","author":"Yi","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2007.03.001_bib45","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1128\/JVI.73.4.3443-3448.1999","article-title":"Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?","volume":"73","author":"Zhang","year":"1999","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virol.2007.03.001_bib46","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1128\/JVI.72.11.9337-9344.1998","article-title":"Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro","volume":"72","author":"Zhang","year":"1998","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682207001420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682207001420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:47:54Z","timestamp":1758584874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682207001420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0042682207001420"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2007.03.001","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2007.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}